{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:48:24Z","timestamp":1794023304802,"version":"4.8.0"},"reference-count":212,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>All nations which have undergone a nutrition transition have experienced increased frequency and falling latency of chronic degenerative diseases, which are largely driven by chronic inflammatory stress. Dietary supplementation is a valid strategy to reduce the risk and severity of such disorders. Palmitoylethanolamide (PEA) is an endocannabinoid-like lipid mediator with extensively documented anti-inflammatory, analgesic, antimicrobial, immunomodulatory and neuroprotective effects. It is well tolerated and devoid of side effects in animals and humans. PEA\u2019s actions on multiple molecular targets while modulating multiple inflammatory mediators provide therapeutic benefits in many applications, including immunity, brain health, allergy, pain modulation, joint health, sleep and recovery. PEA\u2019s poor oral bioavailability, a major obstacle in early research, has been overcome by advanced delivery systems now licensed as food supplements. This review summarizes the functionality of PEA, supporting its use as an important dietary supplement for lifestyle management.<\/jats:p>","DOI":"10.3390\/ijms22105305","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T12:17:16Z","timestamp":1621340236000},"page":"5305","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Palmitoylethanolamide: A Natural Compound for Health Management"],"prefix":"10.3390","volume":"22","author":[{"given":"Paul","family":"Clayton","sequence":"first","affiliation":[{"name":"Institute of Food, Brain and Behaviour, Beaver House, 23-28 Hythe Bridge Street, Oxford OX1 2EP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Hill","sequence":"additional","affiliation":[{"name":"Gencor Pacific Limited, Discovery Bay, Lantau Island, New Territories, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathasha","family":"Bogoda","sequence":"additional","affiliation":[{"name":"Gencor Pacific Limited, Discovery Bay, Lantau Island, New Territories, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silma","family":"Subah","sequence":"additional","affiliation":[{"name":"Gencor Pacific Limited, Discovery Bay, Lantau Island, New Territories, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchitha","family":"Venkatesh","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1111\/j.1753-4887.2004.tb00084.x","article-title":"The nutrition transition: An overview of world patterns of change","volume":"62","author":"Popkin","year":"2004","journal-title":"Nutr. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41576-018-0012-3","article-title":"The transition to modernity and chronic disease: Mismatch and natural selection","volume":"19","author":"Corbett","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_3","first-page":"15","article-title":"The western diet and lifestyle and diseases of civilization","volume":"2","author":"Lindeberg","year":"2011","journal-title":"Res. Rep. Clin. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the lifespan","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3803\/EnM.2015.30.2.159","article-title":"New Directions in Chronic Disease Management","volume":"30","author":"Kim","year":"2015","journal-title":"Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/embor.2012.142","article-title":"The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment","volume":"13","author":"Hunter","year":"2012","journal-title":"EMBO Rep."},{"key":"ref_7","unstructured":"Pahwa, R., Goyal, A., Bansal, P., and Jialal, I. (2020). Chronic Inflammation, StatPearls Publishing."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/0973-1229.58817","article-title":"Modern Medicine: Towards Prevention, Cure, Well-being and Longevity","volume":"8","author":"Singh","year":"2010","journal-title":"Mens Sana Monogr."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Rankin, L., and Fowler, C.J. (2020). The Basal Pharmacology of Palmitoylethanolamide. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217942"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrendo.2016.54","article-title":"Dietary supplements and disease prevention\u2014A global overview","volume":"12","author":"Rautiainen","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Blumberg, J.B., Bailey, R.L., Sesso, H.D., and Ulrich, C.M. (2018). The Evolving Role of Multivitamin\/Multimineral Supplement Use among Adults in the Age of Personalized Nutrition. Nutrients, 10.","DOI":"10.3390\/nu10020248"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF02877718","article-title":"Nutritional supplementation: Is it necessary for everybody?","volume":"24","author":"Wienecke","year":"2007","journal-title":"Adv. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1475-2891-13-72","article-title":"Addressing nutritional gaps with multivitamin and mineral supplements","volume":"13","author":"Ward","year":"2014","journal-title":"Nutr. J."},{"key":"ref_14","first-page":"138","article-title":"Strategies to increase the activity of microglia as efficient protectors of the brain against infections","volume":"22","author":"Nau","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4720532","DOI":"10.1155\/2018\/4720532","article-title":"Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer\u2019s Disease: In Vitro and In Vivo Evidence","volume":"2018","author":"Bronzuoli","year":"2018","journal-title":"Oxid Med. Cell Longev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3389\/fphar.2019.00821","article-title":"Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer\u2019s Disease","volume":"24","author":"Beggiato","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/npp.2012.25","article-title":"Palmitoylethanolamide protects against the amyloid-\u03b225-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease","volume":"37","author":"Russo","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1871527311312010010","article-title":"Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries","volume":"12","author":"Esposito","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e1419","DOI":"10.1038\/cddis.2014.376","article-title":"Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer\u2019s disease","volume":"11","author":"Scuderi","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_20","first-page":"237","article-title":"Co-ultra micronized palmitoylethanolamide\/luteolin treatment as add-on to intensive neuro-rehabilitation in a young patient with traumatic brain injury","volume":"177","author":"Santamato","year":"2018","journal-title":"Gazz Med. Ital. Arch. Sci. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2012.11.017","article-title":"Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-\u03b1 receptor activation in a genetic model of absence epilepsy","volume":"69","author":"Citraro","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bph.12907","article-title":"Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent","volume":"172","author":"Borrelli","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/bph.13580","article-title":"The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations","volume":"174","author":"Petrosino","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_24","first-page":"151028","article-title":"Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold","volume":"2013","author":"Witkamp","year":"2013","journal-title":"Int. J. Inflam."},{"key":"ref_25","first-page":"1","article-title":"Professor Rita Levi-Montalcini on Nerve Growth Factor, mast cells and palmitoylethanolamide, an endogenous anti-inflammatory and analgesic compound","volume":"2","year":"2013","journal-title":"Pain Relief."},{"key":"ref_26","first-page":"325061","article-title":"Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases","volume":"2015","author":"Antonucci","year":"2015","journal-title":"Case Rep. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/bcp.13020","article-title":"Palmitoylethanolamide for the treatment of pain: Pharmacokinetics, safety and efficacy","volume":"82","author":"Gabrielsson","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2018.02.057","article-title":"Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial","volume":"232","author":"Ghajar","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10787-019-00582-9","article-title":"Double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis","volume":"27","author":"Steels","year":"2019","journal-title":"Inflammopharmacology"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hauer, D., Schelling, G., Gola, H., Campolongo, P., Morath, J., Roozendaal, B., Hamuni, G., Karabatsiakis, A., Atsak, P., and Vogeser, M. (2013). Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062741"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mallard, A., Briskey, D., Richards, A., Mills, D., and Rao, A. (2020). The Effect of Orally Dosed Levagen+\u00ae (palmitoylethanolamide) on Exercise Recovery in Healthy Males-A Double-Blind, Randomized, Placebo-Controlled Study. Nutrients, 12.","DOI":"10.3390\/nu12030596"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1007\/s12035-016-0313-5","article-title":"Endocannabinoid System: The Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review","volume":"54","author":"Dzik","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/1871527316666170321124949","article-title":"Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson\u2019s Disease","volume":"16","author":"Brotini","year":"2017","journal-title":"CNS Neurol. Disord Drug Targets"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/1871527317666180420143830","article-title":"Ultra-micronized palmitoylethanolamide effects on sleep-wake rhythm and neuropathic pain phenotypes in patients with carpal tunnel syndrome: An open-label, randomized controlled study","volume":"17","author":"Evangelista","year":"2018","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11552-011-9373-1","article-title":"Characteristics of sleep disturbance in patients with carpal tunnel syndrome","volume":"7","author":"Patel","year":"2012","journal-title":"Hand"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gugliandolo, E., Peritore, A.F., Piras, C., Cuzzocrea, S., and Crupi, R. (2020). Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing. Vet. Sci., 7.","DOI":"10.3390\/vetsci7020078"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/imm.12170","article-title":"Mast cells, glia and neuroinflammation: Partners in crime?","volume":"141","author":"Skaper","year":"2014","journal-title":"Immunology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2147\/JPR.S48653","article-title":"Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: From nonspecific resistance to PPAR-\u03b1 agonist and effective nutraceutical","volume":"6","author":"Hesselink","year":"2013","journal-title":"J. Pain Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/SHK.0b013e318267bbb9","article-title":"Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice","volume":"38","author":"Impellizzeri","year":"2012","journal-title":"Shock"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","article-title":"Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide","volume":"92","author":"Facci","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.vetimm.2009.06.011","article-title":"Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNF\u03b1 release from canine skin mast cells","volume":"133","author":"Cerrato","year":"2010","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3389\/fimmu.2018.02671","article-title":"Prophylactic palmitoylethanolamide prolongs survival and decreases detrimental inflammation in aged mice with bacterial meningitis","volume":"9","author":"Heide","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/IAI.01110-09","article-title":"Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia","volume":"78","author":"Ribes","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1460-9568.2008.06377.x","article-title":"Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide","volume":"28","author":"Petrosino","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1084\/jem.100.5.425","article-title":"The Effect Of Egg Yolk In Diets On Anaphylactic Arthritis (Passive Arthus Phenomenon) In The Guinea Pig","volume":"100","author":"Coburn","year":"1954","journal-title":"J. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3389\/fphar.2017.00857","article-title":"Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse","volume":"8","author":"Roviezzo","year":"2017","journal-title":"Front. Pharmcol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.tvjl.2011.04.002","article-title":"Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs","volume":"191","author":"Cerrato","year":"2012","journal-title":"Vet. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-3164.2001.00214.x","article-title":"Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: A pilot study","volume":"12","author":"Scarampella","year":"2001","journal-title":"Vet. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/vde.12250","article-title":"Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: An open label multi-centre study","volume":"26","author":"Noli","year":"2015","journal-title":"Vet. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1398-9995.2009.02254.x","article-title":"Protective role of palmitoylethanolamide in contact allergic dermatitis","volume":"65","author":"Petrosino","year":"2010","journal-title":"Allergy"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ejphar.2016.10.005","article-title":"Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis","volume":"791","author":"Vaia","year":"2016","journal-title":"Eur. J. Pharmcol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-6148-10-21","article-title":"Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis","volume":"10","author":"Abramo","year":"2014","journal-title":"BMC Vet. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2007.02351.x","article-title":"Adjuvant treatment of atopic eczema: Assessment of an emollient containing N-palmitoylethanolamide (ATOPA study)","volume":"22","author":"Eberlien","year":"2008","journal-title":"J. Eur. Dermatol. Venereol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1111\/j.1582-4934.2011.01267.x","article-title":"Palmitoylethanolamide counteracts reactive astrogliosis induced by \u03b2-amyloid peptide","volume":"15","author":"Scuderi","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1871527311312010011","article-title":"Neuroglial roots of neurodegenerative diseases: Therapeutic potential of palmitoylethanolamide in models of Alzheimer\u2019s disease","volume":"12","author":"Scuderi","year":"2013","journal-title":"CNS. Neurol. Disord. Drug. Targets"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12975-015-0440-8","article-title":"Stroke Study Group. Co-ultramicronized Palmitoylethanolamide\/Luteolin in the Treatment of Cerebral Ischemia: From Rodent to Man","volume":"7","author":"Caltagirone","year":"2016","journal-title":"Transl. Stroke. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/neu.2014.3460","article-title":"Neuroprotective Effects of Co-UltraPEALut on Secondary Inflammatory Process and Autophagy Involved in Traumatic Brain Injury","volume":"33","author":"Cordaro","year":"2016","journal-title":"J. Neurotrauma."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbi.2012.07.021","article-title":"Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice","volume":"26","author":"Ahmad","year":"2012","journal-title":"Brain. Behav. Immun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cns.12648","article-title":"Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide\/Luteolin in a Mouse Model of Autism and in a Case Report of Autism","volume":"23","author":"Bertolino","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3389\/fneur.2018.00674","article-title":"Effects of Add-On Ultramicronized N-Palmitol Ethanol Amide in Patients Suffering of Migraine With Aura: A Pilot Study","volume":"17","author":"Chirchiglia","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12974-014-0136-0","article-title":"Micronized\/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to non-micronized palmitoylethanolamide in a rat model of inflammatory pain","volume":"11","author":"Impellizzeri","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.pain.2008.06.003","article-title":"The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: Involvement of CB1, TRPV1 and PPAR\u03b3 receptors and neurotrophic factors","volume":"139","author":"Costa","year":"2008","journal-title":"Pain"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1871527311312010008","article-title":"Non-neuronal cell modulation relieves neuropathic pain: Efficacy of the endogenous lipid palmitoylethanolamide","volume":"12","author":"Bettoni","year":"2013","journal-title":"Cns Neurol. Disord. Drug Targets"},{"key":"ref_65","first-page":"99","article-title":"Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain","volume":"26","author":"Marini","year":"2012","journal-title":"J. Orofac. Pain"},{"key":"ref_66","first-page":"35","article-title":"La palmitoilethanolamida (Normast\u00ae) en el dolor neurop\u00e1tico cr\u00f3nico por lumbociatalgia de tipo compresivo: Estudio cl\u00ednico multic\u00e9ntrico","volume":"25","author":"Guida","year":"2010","journal-title":"Dolor"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2147\/JPR.S93106","article-title":"Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: Efficacy and safety in sciatic pain and carpal tunnel syndrome","volume":"8","author":"Hesselink","year":"2015","journal-title":"J. Pain Res."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Schifilliti, C., Cucinotta, L., Fedele, V., Ingegnosi, C., Luca, S., and Leotta, C. (2014). Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients. Pain Res. Treat., 2014.","DOI":"10.1155\/2014\/849623"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Bacci, C., Cassetta, G., Emanuele, B., and Berengo, M. (2011). Randomized split-mouth study on postoperative effects of palmitoylethanolamide for impacted lower third molar surgery. Int. Sch. Res. Netw., 2011.","DOI":"10.5402\/2011\/917350"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40122-015-0038-6","article-title":"Palmitoylethanolamide in fibromyalgia: Results from prospective and retrospective observational studies","volume":"4","author":"Skaper","year":"2015","journal-title":"Pain Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pain.2007.03.012","article-title":"Mast cell degranulation activates a pain pathway underlying migraine headache","volume":"130","author":"Levy","year":"2007","journal-title":"Pain"},{"key":"ref_72","first-page":"1","article-title":"Ultramicronized palmitoylethanolamide reduces frequency and pain intensity in migraine. A pilot study","volume":"3","author":"Zavarize","year":"2016","journal-title":"Int. J. Neurol. Brain. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.AOG.0000230214.26638.0c","article-title":"Primary dysmenorrhea: Advances in pathogenesis and management","volume":"108","author":"Dawood","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpag.2014.12.011","article-title":"Effectiveness of the Association N-Palmitoylethanolamine and Transpolydatin in the Treatment of Primary Dysmenorrhea","volume":"28","author":"Tartaglia","year":"2015","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/j.pain.0000000000000220","article-title":"Ultramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: Role of mast cells","volume":"157","author":"Iuvone","year":"2016","journal-title":"Pain"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejogrb.2010.01.008","article-title":"Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: Preliminary observations","volume":"150","author":"Indraccolo","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejogrb.2011.04.011","article-title":"Effectiveness of the association micronized N-Palmitoylethanolamie (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: A pilot study","volume":"158","author":"Cobellis","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.joca.2008.03.002","article-title":"Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis","volume":"16","author":"Brien","year":"2008","journal-title":"Osteoarthr. Cartil."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Cordaro, M., Cuzzocrea, S., and Crupi, R. (2020). An update of palmitoylethanolamide and luteolin effects in preclinical and clinical studies of neuroinflammatory events. Antioxidants, 9.","DOI":"10.3390\/antiox9030216"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Lee, Y.J., Kim, H.R., Lee, C.Y., Hyun, S.A., Ko, M.Y., Lee, B.S., Hwang, D.Y., and Ka, M. (2020). 2-Phenylethylamine (PEA) Ameliorates Corticosterone-Induced Depression-Like Phenotype via the BDNF\/TrkB\/CREB Signaling Pathway. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239103"},{"key":"ref_81","first-page":"95","article-title":"Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury","volume":"6","author":"Guida","year":"2017","journal-title":"Front. Pharmcol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gutjnl-2013-305005","article-title":"Palmitoylethanolamide improves colon inflammation through an enteric glia\/toll like receptor 4-dependent PPAR-\u03b1 activation","volume":"63","author":"Esposito","year":"2014","journal-title":"Gut"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbi.2019.04.006","article-title":"Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain","volume":"85","author":"Guida","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.2174\/0929867324666170216113756","article-title":"Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases","volume":"25","author":"Russo","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2012.02.023","article-title":"Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut","volume":"141","author":"Maes","year":"2012","journal-title":"J. Affect. Disord."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","article-title":"Immune response in COVID-19: A review","volume":"13","author":"Chowdhury","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Childs, C.E., Calder, P.C., and Miles, E.A. (2019). Diet and Immune Function. Nutrients, 11.","DOI":"10.3390\/nu11081933"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbi.2017.01.021","article-title":"Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: Case-controlled study","volume":"62","author":"Hou","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Peritore, A.F., Siracusa, R., Crupi, R., and Cuzzocrea, S. (2019). Therapeutic efficacy of palmitoylethanolamide and its new formulations in synergy with different antioxidant molecules present in diets. Nutrients, 11.","DOI":"10.3390\/nu11092175"},{"key":"ref_90","first-page":"11","article-title":"Studies on prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin) in acute respiratory infections. Serologically controlled field trials","volume":"23","author":"Kahlich","year":"1979","journal-title":"J. Hyg. Epidemiol. Microbiol. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2011.12.013","article-title":"Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 and Streptococcus pneumoniae R6 by microglial cells","volume":"244","author":"Redlich","year":"2012","journal-title":"J. Neuroimmun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-00342-1","article-title":"Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: Involvement of the CB2 receptor","volume":"7","author":"Guida","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"ref_95","first-page":"1","article-title":"Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza","volume":"13","author":"Pumarola","year":"2009","journal-title":"Crit. Care"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1871527311312010013","article-title":"New insights in mast cell modulation by palmitoylethanolamide","volume":"12","author":"Negro","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000312403","article-title":"Prevention of mast cell degranulation by disodium cromoglycate delayed the regression of hypoxic pulmonary hypertension in rats","volume":"80","author":"Herget","year":"2010","journal-title":"Respiration"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000315947","article-title":"In vitro diagnosis of anaphylaxis","volume":"95","author":"Sanz","year":"2010","journal-title":"Anaphylaxis"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuron.2009.09.033","article-title":"Current challenges in glia-pain biology","volume":"64","author":"McMahon","year":"2009","journal-title":"Neuron"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fncel.2014.00240","article-title":"Never-resting microglia: Physiological roles in the healthy brain and pathological implications","volume":"8","author":"Sierra","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/mol.63.2.429","article-title":"Anandamide inhibits nuclear factor-\u03baB activation through a cannabinoid receptor-independent pathway","volume":"63","author":"Sancho","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbi.2018.09.003","article-title":"Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+ tf\/J mice: Contribution of central and peripheral mechanisms","volume":"74","author":"Cristiano","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Cresci, G.A., and Izzo, K. (2019). Gut Microbiome. Adult Short Bowel Syndrome, Academic Press.","DOI":"10.1016\/B978-0-12-814330-8.00004-4"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/bph.13084","article-title":"The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels","volume":"173","author":"Petrosino","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0090-6980(02)00053-9","article-title":"Endocannabinoid hydrolases","volume":"68","author":"Ueda","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2222.2007.02886.x","article-title":"The mast cell and allergic diseases: Role in pathogenesis and implications for therapy","volume":"38","author":"Brown","year":"2007","journal-title":"Clin. Exp. Allergy"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.coi.2009.09.006","article-title":"Mast cells in atopic dermatitis","volume":"21","author":"Kawakami","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat. Med."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Esposito, E., Impellizzeri, D., Mazzon, E., Paterniti, I., and Cuzzocrea, S. (2012). Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson\u2019s disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041880"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fnins.2018.00145","article-title":"Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain","volume":"28","author":"Herrera","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"23481","DOI":"10.1038\/srep23481","article-title":"N-Palmitoylethanolamine Prevents the Run-down of Amplitudes in Cortical Spreading Depression Possibly Implicating Proinflammatory Cytokine Release","volume":"6","author":"Richter","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","article-title":"Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress","volume":"34","author":"Hill","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-993211","article-title":"Serum endocannabinoid content is altered in females with depressive disorders: A preliminary report","volume":"41","author":"Hill","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1523\/JNEUROSCI.3561-14.2015","article-title":"Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats: A priming stimulus of microglia and the NLRP3 inflammasome","volume":"35","author":"Weber","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Barbierato, M., Facci, L., Marinelli, C., Zusso, M., Argentini, C., Skaper, S.D., and Giusti, P. (2015). Co-ultramicronized Palmitoylethanolamide\/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells. Sci. Rep., 5.","DOI":"10.1038\/srep16676"},{"key":"ref_116","first-page":"203","article-title":"The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s13311-017-0585-0","article-title":"Anxiety, depression, and the microbiome: A role for gut peptides","volume":"15","author":"Lach","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.201500132","article-title":"Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPAR\u03b1","volume":"31","author":"Karwad","year":"2017","journal-title":"FASEB J."},{"key":"ref_119","first-page":"2037838","article-title":"Gut microbiome dysbiosis and immunometabolism: New frontiers for treatment of metabolic diseases","volume":"2018","author":"Faintuch","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.euroneuro.2017.08.433","article-title":"Treatment with a GLP\u2212 1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders","volume":"27","author":"Mansur","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s12325-019-01053-x","article-title":"Towards an Effective and Safe Treatment of Inflammatory Pain: A Delphi-Guided Expert Consensus","volume":"36","author":"Varrassi","year":"2019","journal-title":"Adv. Thr."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Suzuki, K. (2019). Chronic Inflammation as an Immunological Abnormality and Effectiveness of Exercise. Biomolecules, 9.","DOI":"10.3390\/biom9060223"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00401-013-1092-y","article-title":"The role of mast cells in neuroinflammation","volume":"125","author":"Nelissen","year":"2013","journal-title":"Acta. Neuropathol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1098\/rstb.2011.0391","article-title":"Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/IJWH.S204275","article-title":"Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide\/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study","volume":"11","author":"Loi","year":"2019","journal-title":"Int. J. Womens Health"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"E249","DOI":"10.1016\/j.bja.2019.02.019","article-title":"Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity","volume":"123","author":"Habib","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Fu","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmcol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3580249","article-title":"Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells","volume":"358","author":"Melck","year":"2001","journal-title":"Biochem. J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjp.2008.324","article-title":"\u201cEntourage\u201d effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors","volume":"155","author":"Ho","year":"2008","journal-title":"Br. J. Pharmcol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2009.04.022","article-title":"Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-\u03baB nuclear signalling in dorsal root ganglia","volume":"613","author":"Russo","year":"2009","journal-title":"Eur. J. Pharmcol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbi.2011.02.006","article-title":"Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury","volume":"25","author":"Esposito","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1871527311312010009","article-title":"Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial\/microglial phenotypical changes in mice","volume":"12","author":"Luongo","year":"2013","journal-title":"Cns Neurol. Disord. Drug Targets."},{"key":"ref_134","first-page":"328797","article-title":"Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: Pain relief and neuroprotection share a PPAR-alpha-mediated mechanism","volume":"2013","author":"Mannelli","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3399\/bjgp16X684433","article-title":"The dangers of NAIDS: Look both ways","volume":"66","author":"Davis","year":"2016","journal-title":"Br. J. Gen. Pract."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjmed.2017.09.005","article-title":"Headache","volume":"131","author":"Rizzoli","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Straube, A., and Andreou, A. (2019). Primary headaches during lifespan. J. Headache Pain, 1\u201314.","DOI":"10.1186\/s10194-019-0985-0"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Stovner","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1468-2982.2003.00644.x","article-title":"Neurobiology of Chronic Tension-Type Headache","volume":"24","author":"Ashina","year":"2004","journal-title":"Cephalalgia"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11916-006-0042-y","article-title":"Is migraine a neuropathic pain syndrome?","volume":"10","author":"Biondi","year":"2006","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Papetti, L., Sforza, G., Tullo, G., di Loro, P.A., Moavero, R., Ursitti, F., Ferilli, M.A.N., Tarantino, S., Vigevano, F., and Valeriani, M. (2020). Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study. Pain Res. Manag., 2020.","DOI":"10.1155\/2020\/3938640"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.12688\/f1000research.11682.1","article-title":"Dysmenorrhea and related disorders","volume":"6","author":"Bernardi","year":"2017","journal-title":"F1000Res"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jpag.2013.06.018","article-title":"Assessment of Anxiety and Depression in Adolescents with Primary Dysmenorrhea: A Case-Control Study","volume":"26","author":"Gagua","year":"2013","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejogrb.2013.07.004","article-title":"The effectiveness of an educational intervention on proper analgesic use for dysmenorrhea","volume":"170","author":"Jung","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jpag.2006.09.001","article-title":"Dysmenorrhea in adolescents and young adults: Etiology and management","volume":"19","author":"Harel","year":"2006","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejogrb.2013.01.009","article-title":"The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain","volume":"168","author":"Giugliano","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2105\/AJPH.2018.304747","article-title":"The global burden of musculoskeletal pain\u2014Where to from here?","volume":"109","author":"Blyth","year":"2019","journal-title":"Am. J. Public Health"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s11914-018-0493-1","article-title":"Mechanisms underlying bone and joint pain","volume":"16","author":"Havelin","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cger.2010.03.002","article-title":"Age-related changes in the musculoskeletal system and the development of osteoarthritis","volume":"26","author":"Loeser","year":"2010","journal-title":"Clin. Geriatr. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/CMAMD.S14386","article-title":"Osteoarthritis in young, active, and athletic individuals","volume":"7","author":"Amoako","year":"2014","journal-title":"Clin. Med. Insights Arthritis Musculoskelet. Disord."},{"key":"ref_151","first-page":"85","article-title":"Knee osteoarthritis related pain: A narrative review of diagnosis and treatment","volume":"8","author":"Alshami","year":"2014","journal-title":"Int. J. Health Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"11","DOI":"10.36076\/ppj\/2016.19.11","article-title":"Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: A pooled data meta-analysis","volume":"19","author":"Einaudi","year":"2016","journal-title":"Pain Physician"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/acr.20142","article-title":"The nerve of osteoarthritis pain","volume":"62","author":"Hochman","year":"2010","journal-title":"Arthritis Care Res."},{"key":"ref_154","first-page":"37","article-title":"Osteoarthritis pathogenesis\u2013a complex process that involves the entire joint","volume":"7","author":"Man","year":"2017","journal-title":"J. Med. Life"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/boneres.2016.44","article-title":"Osteoarthritis: Toward a comprehensive understanding of pathological mechanism","volume":"5","author":"Chen","year":"2017","journal-title":"Bone Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ijom.2010.06.003","article-title":"Analysis of thermal pain sensitivity and psychological profiles in different subgroups of TMD patients","volume":"39","author":"Park","year":"2010","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/1874312901206010320","article-title":"Pain treatment in arthritis-related pain: Beyond NSAIDs","volume":"6","author":"Pergolizzi","year":"2012","journal-title":"Open Rheumatol. J."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Maseda, D., and Ricciotti, E. (2020). NSAID\u2013Gut Microbiota Interactions. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01153"},{"key":"ref_159","first-page":"S105","article-title":"Opioid complications and side effects","volume":"11","year":"2008","journal-title":"Pain Physician"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejpain.2006.02.013","article-title":"Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials","volume":"11","author":"Bjordal","year":"2007","journal-title":"Eur. J. Pain"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","article-title":"Glucosamine sulfate use and delay of progression of knee osteoarthritis: A 3-year, randomized, placebo-controlled, double-blind study","volume":"162","author":"Machacek","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"ref_162","first-page":"19","article-title":"The effect of methylsulfonylmethane on osteoarthritic large joints and mobility","volume":"1","author":"Pagonis","year":"2014","journal-title":"Int. J. Orthop."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3657","article-title":"Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?","volume":"14","author":"Henrotin","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_165","first-page":"1","article-title":"Effects of diet type and supplementation of glucosamine, chondroitin, and MSM on body composition, functional status, and markers of health in women with knee osteoarthritis initiating a resistance-based exercise and weight loss program","volume":"8","author":"Wilborn","year":"2011","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"9","DOI":"10.11648\/j.ijnfs.20211001.12","article-title":"The Effect of a Dispersible Palmitoylethanolamide (Levagen+) Compared to a Placebo for Reducing Joint Pain in an Adult Population\u2013A Randomised, Double-Blind Study","volume":"10","author":"Briskey","year":"2021","journal-title":"Int. J. Nutr. Food Sci."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Manickam, R., Duszka, K., and Wahli, W. (2020). PPARs and Microbiota in Skeletal Muscle Health and Wasting. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218056"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s12035-015-9253-8","article-title":"N-Palmitoylethanolamine and neuroinflammation: A novel therapeutic strategy of resolution","volume":"52","author":"Skaper","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12035-013-8487-6","article-title":"Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator","volume":"48","author":"Skaper","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.drudis.2014.06.007","article-title":"Harnessing the anti-inflammatory potential of palmitoylethanolamide","volume":"19","author":"Alhouayek","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1517\/13543784.14.6.695","article-title":"Therapeutic potential of cannabinoid receptor agonists as analgesic agents","volume":"14","author":"Fox","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/gerona\/56.suppl_2.13","article-title":"Physical activity in aging: Changes in patterns and their relationship to health and function","volume":"56","author":"DiPietro","year":"2001","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00002060-200211001-00007","article-title":"Exercise-induced muscle damage in humans","volume":"81","author":"Clarkson","year":"2002","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/02640419608727714","article-title":"Muscle tenderness and peak torque changes after downhill running following a prior bout of isokinetic eccentric exercise","volume":"14","author":"Eston","year":"1996","journal-title":"J. Sports Sci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s40279-016-0640-8","article-title":"Frequency: The overlooked resistance training variable for inducing muscle hypertrophy?","volume":"47","author":"Dankel","year":"2017","journal-title":"Sports Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/mus.24077","article-title":"Lengthening our perspective: Morphological, cellular, and molecular responses to eccentric exercise","volume":"49","author":"Hyldahl","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1152\/japplphysiol.00971.2016","article-title":"Muscle damage and inflammation during recovery from exercise","volume":"122","author":"Peake","year":"2017","journal-title":"J. Appl. Physiol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1515\/CCLM.2010.179","article-title":"Biochemical markers of muscular damage","volume":"48","author":"Brancaccio","year":"2010","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00007256-198603010-00003","article-title":"Blood lactate","volume":"3","author":"Jacobs","year":"1986","journal-title":"Sports Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00007256-200434010-00005","article-title":"Neuromuscular function after exercise-induced muscle damage","volume":"34","author":"Byrne","year":"2004","journal-title":"Sports Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/BF03262309","article-title":"The Use of Nonsteroidal anti-inflammatory drugs for exercise-induced muscle damage","volume":"42","author":"Schoenfeld","year":"2012","journal-title":"Sports Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000489287","article-title":"The trouble with CBD oil","volume":"1","author":"Hazekamp","year":"2018","journal-title":"Med. Cannabis Cannabinoids"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2174\/1570159X17666190603171901","article-title":"Cannabidiol adverse effects and toxicity","volume":"17","author":"Huestis","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"ref_185","unstructured":"Liebling, J.P., Clarkson, N.J., Gibbs, B.W., Yates, A.S., and O\u2019Sullivan, S.E. (2020). An analysis of over-the-counter cannabidiol products in the United Kingdom. Cannabis Cannabinoid Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1089\/can.2019.0101","article-title":"Labeling of cannabidiol products: A public health perspective","volume":"5","author":"Corroon","year":"2020","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40798-018-0176-6","article-title":"Nutritional and supplementation strategies to prevent and attenuate exercise-induced muscle damage: A brief review","volume":"5","author":"Harty","year":"2019","journal-title":"Sports Med. Open"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1128\/MCB.18.7.3708","article-title":"Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport","volume":"18","author":"Kitamura","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17461391.2018.1505957","article-title":"Exercise-induced muscle damage: What is it, what causes it and what are the nutritional solutions?","volume":"19","author":"Owens","year":"2019","journal-title":"Eur. J. Sport Sci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnmol.2020.00125","article-title":"Cannabinoids, endocannabinoids and sleep","volume":"13","author":"Kesner","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_191","first-page":"758","article-title":"The extraordinary importance of sleep; The detrimental effects of inadequate sleep on health and public safety drive and explosion of sleep research","volume":"43","author":"Worley","year":"2018","journal-title":"PT"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1101\/lm.58503","article-title":"Sleep and time course of motor skill learning","volume":"10","author":"Walker","year":"2003","journal-title":"Learn. Mem."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/01.HYP.0000217362.34748.e0","article-title":"Short sleep duration as a risk factor for hypertension: Analyses of the first National Health and Nutrition Examination Survey","volume":"47","author":"Gangwisch","year":"2006","journal-title":"Hypertension"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-444-53702-7.00007-5","article-title":"Effects of sleep deprivation on cognition","volume":"185","author":"Killgore","year":"2010","journal-title":"Prog. Brain Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5664\/jcsm.26918","article-title":"Behavioral and physiological consequences of sleep restriction","volume":"3","author":"Banks","year":"2007","journal-title":"J. Clin. Sleep Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/NSS.S134864","article-title":"Short- and long-term health consequences of sleep disruption","volume":"9","author":"Medic","year":"2017","journal-title":"Nat. Sci. Sleep"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"12710","DOI":"10.1111\/jsr.12710","article-title":"The impact of stress on sleep: Pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders","volume":"27","author":"Kalmbach","year":"2018","journal-title":"J. Sleep Res."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Murase, K., Tabara, Y., Ito, H., Kobayashi, M., Takahashi, Y., Setoh, K., Kawaguchi, T., Muro, S., Kadotani, H., and Kosugi, S. (2015). Knee Pain and Low Back Pain Additively Disturb Sleep in the General Population: A Cross-Sectional Analysis of the Nagahama Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140058"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1734-1140(11)70596-5","article-title":"N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice","volume":"63","author":"Yu","year":"2011","journal-title":"Pharmcol. Rep."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/sleep\/33.5.585","article-title":"Sleep duration and all-cause mortality: A systematic review and meta-analysis of prospective studies","volume":"33","author":"Cappuccio","year":"2010","journal-title":"Sleep"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jpain.2016.01.474","article-title":"Pain Sensitivity in Patients With Major Depression: Differential Effect of Pain Sensitivity Measures, Somatic Cofactors, and Disease Characteristics","volume":"17","author":"Hermesdorf","year":"2016","journal-title":"J. Pain"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref_203","first-page":"30197","article-title":"The relationship of endocannabinoidome lipid medi- ators with pain and psychological stress in women with fibromyalgia: A case-control study","volume":"18","author":"Stensson","year":"2018","journal-title":"J. Pain"},{"key":"ref_204","first-page":"269","article-title":"Neurological and emotional profile of carpal tunnel syndrome patients","volume":"68","author":"Pogorzelski","year":"2011","journal-title":"Przegl Lek."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"e017732","DOI":"10.1136\/bmjopen-2017-017732","article-title":"Association of psychological distress, quality of life and costs with carpal tunnel syndrome severity: A cross-sectional analysis of the PALMS cohort","volume":"7","author":"Houghton","year":"2017","journal-title":"BMJ Open"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Murillo-Rodr\u00edguez, E., Palomero-Rivero, M., Mill\u00e1n-Aldaco, D., Arias-Carri\u00f3n, O., and Drucker-Col\u00edn, R. (2011). Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020766"},{"key":"ref_207","first-page":"3","article-title":"Increased Absorption of Palmitoylethanolamide Using a Novel Dispersion Technology System (LipiSperse\u00ae)","volume":"5","author":"Briskey","year":"2020","journal-title":"J. Nutraceuticals Food Sci."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/PDT-120027417","article-title":"Micron-size drug particles: Common and novel micronization techniques","volume":"9","author":"Rasenack","year":"2004","journal-title":"Pharm. Dev. Technol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fphar.2018.00249","article-title":"Oral ultramicronized palmitoylethanolamide: Plasma and tissue levels and spinal anti-hyperalgesic effect","volume":"9","author":"Petrosino","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00394-018-1766-2","article-title":"Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse\u00ae)","volume":"58","author":"Briskey","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Briskey, D., and Rao, A. (2020). Trans-resveratrol Oral Bioavailability in Humans using Lipisperse\u00ae Dispersion Technology. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12121190"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871527311312010007","article-title":"Measurement of palmitoylethanolamide and other N-acylethanolamines during physiological and pathological conditions","volume":"12","author":"Balvers","year":"2013","journal-title":"CNS Neurol. Disord Drug Targets"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/10\/5305\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:03:15Z","timestamp":1760162595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/10\/5305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":212,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijms22105305"],"URL":"https:\/\/doi.org\/10.3390\/ijms22105305","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]}}}